Single-cell multi-omic studies have recently revealed specific patterns of clonal evolution driving the progression of MDS to AML-MRC [12,13], further highlighting that high-risk MDS and AML-MRC probably represent different stages of the same myeloid disease. This evidence concerns the gene CD200 and myelodysplastic syndrome.